Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cuprizone neurotoxicity in the rat: morphologic observations.
Episode 13 with Professor Alan Thompson on the International Progressive MS Alliance.
Genes associated with T helper 17 cell differentiation and function.
Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
B1 cells are unaffected by immune modulatory treatment in remitting-relapsing multiple sclerosis patients.
Breastfeeding is not related to postpartum relapses in multiple sclerosis.
Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone.
Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.
Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.
Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study.
Keystone Symposium: Viral Immunity
Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model.
American Academy of Neurology Annual Meeting
Immunology 2015
Biogen Idec's TECFIDERA™ (dimethyl fumarate) approved in US as a first-line oral treatment for multiple sclerosis
A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.
“Human Medicines” page
MS Frontiers 2015
Randomized trial of oral teriflunomide for relapsing multiple sclerosis.
Checklist for reporting and reviewing studies of experimental animal models of multiple sclerosis and related disorders.
Webinar: "Seeking Best Practices in Classifier Construction and Testing"
T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion.
Long-term efficacy and safety of transanal irrigation in multiple sclerosis.
Pages
« first
‹ previous
…
58
59
60
61
62
63
64
65
66
…
next ›
last »